OncoCyte Corporation
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides custom drug target discovery; assay design, development, and validation; and clinical trial and other testing services for pharmaceutical companies. OncoCyte Corporation has a strategic collaboration with Gruppo Oncologico del Nord-Ovest of Pisa to evaluate DetermaIO as a biomarker for immunotherapy response in metastatic colorectal cancer; and Echelon Diagnostics, Inc. The company was founded in 2009 and is headquartered in Irvine, California. Show More...
-
Website https://oncocyte.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 3.32 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.54 -0.77 -0.42 -0.42 -0.64 -0.42 -0.44 -0.49 Dividends USD Payout Ratio % * Shares Mil 6.0 6.0 21.0 27.0 30.0 38.0 51.0 55.0 Book Value Per Share * USD 0.35 0.44 0.26 0.18 0.51 0.54 Free Cash Flow Per Share * USD -0.52 -0.25 -0.43 -0.35 -0.35 Return on Assets % -42.17 -68.1 -91.53 -82.18 -157.12 -159.66 -90.84 -51.97 Financial Leverage (Average) 2.29 1.22 1.46 2.32 2.78 1.29 1.62 Return on Equity % -96.68 -392.44 -186.98 -110.14 -271.64 -402.61 -130.91 -70.29 Return on Invested Capital % -96.68 -392.29 -186.58 -104.59 -221.81 -258.06 -105.58 -62.83 Interest Coverage -458.74 -397.86 -88.29 -71.94 -74.0 -89.69 Current Ratio 1.04 0.49 4.72 2.97 1.91 1.55 5.17 2.62 Quick Ratio 1.01 0.47 4.55 2.9 1.88 1.52 5.06 2.44 Debt/Equity 0.03 0.31 0.15 0.15 0.13